Spotlight Session - Pediatrics

(A25) An Observational Post Approval Safety Study of Etanercept and Methotrexate in Treatment of Juvenile Idiopathic Arthritis (JIA) using the German Biologics JIA Registry (BIKER)

(A26) Antiepileptic Drug Use in Children Beyond Epilepsy: A Population-Based Longitudinal Study

(A27) Incidence of COVID-19 disease severity in a cohort of 4.4 million Italian and Spanish children from 6 healthcare databases

(A28) Metrics of Antibiotic Use in Neonatal Intensive Care Units

(A29) Natural History of RSV Infection in Outpatient Pediatric Patients in the United States

(A30) Overview of Global Real World Data Sources for Pediatric Pharmacoepidemiologic Research

(A31) Population-Based Incidence of Influenza-Associated Serious Neuropsychiatric Events

(A32) Utilization of beta-blockers among the pediatric population in the United States: a study in the FDA’s Sentinel System from 2008 to 2022